Adoptive transfer of in vivo -primed CD8 + T cells or in vitro -generated effector memory CD8 + T (T EFF)
Asthma is a multifactorial infl ammatory disorder arising as a result of the cellular and molecular responses induced by allergen exposure in sensitized hosts. Allergic asthma is characterized by persistent airway infl ammation and airway hyperresponsiveness (AHR) ( 1 ) . From several clinical and experimental investigations ( 2 -5 ) , antigen-specifi c memory T cells, especially CD4 + T cells, were shown to play an integral role in orchestrating the disease process through the secretion of a variety of Th2 cytokines, including IL-4, IL-5, and IL-13, which induce the development of AHR and eosinophilic infl ammation. It has also been reported that the transfer of Th2-type cells in mice induces airway eosinophilia and AHR ( 6 ) .
In addition, there is now increasing evidence for the role of CD8 + T cells in these responses as well. Increased numbers of CD8 + T cells have been shown in the lungs of asthmatic patients ( 7 ) and in animal models of allergic asthma ( 8 ) . We demonstrated that allergenprimed CD8 + T cells were essential for the full development of AHR and airway infl ammation through IL-13 production ( 9 ) . Subsequently, we also reported that in vitro -generated allergenspecifi c eff ector memory CD8 + T (T EFF ) cells contributed to these responses in the challenge phase through their migration into lung tissue and local production of IL-13 in sensitized and challenged mice ( 10 ) . We recently demonstrated the critical role of CD4 + T cells in the sensitization phase for the development of CD8 + T cell -mediated AHR and airway infl ammation ( 11 ) . There are numerous articles addressing the surface after stimulation and is down-regulated by 72 h ( 28 ) . To eff ectively maintain GSI interference in transferred cells, we used a secondary challenge protocol in which the analysis of AHR was completed within 48 h of a single provocative secondary allergen challenge ( 27 ) and transfer of GSI-transferred CD8 + T EFF cells.
Notch1 signaling is activated in T EFF cells after engagement of the TCR
To confi rm Notch1 signaling in CD8 + T EFF cells, we examined Notch1 protein cleavage. Engagement of Notch by any of its ligands results in proteolytic cleavage at an intracellular site between glycine 1743 and valine 1744. This cleavage event, which results in the liberation of NICD, is dependent on the enzymatic activity of the ␥ -secretase complex that contains presenilins and nicastrin ( 29, 30 ) . CD8 + T EFF cells isolated from the lymph nodes or spleens of OT-1 mice were stimulated with anti-CD3 plus anti-CD28 or SIINFEKL peptide in the presence of DMSO (vehicle) or 20 μ M GSI for 24 h. The cell lysates were analyzed by Western blotting for the the molecules that regulate eff ector functions or activation of CD8 + T cells ( 12, 13 ) .
The Notch signaling pathway plays a fundamental role in cell fate decisions in all organisms ( 14 ) . In mammals, there are four identifi ed Notch receptors (Notch1 -4) and fi ve ligands of the Delta-like families (Delta1, Delta3, and Delta4) and Jagged families (Jagged1 and Jagged2) ( 14 ) . Notch receptors and their ligands are also expressed on the surface of mature lymphocytes and APCs. Notch proteins are transcriptional activators expressed fi rst as transmembrane heterodimeric surface receptors. After ligation, Notch undergoes proteolytic processing, including a fi nal cleavage by ␥ -secretase to release the Notch intracellular domain (NICD), which translocates to the nucleus and binds to CSL/RBP-J transcription factor, converting it from a repressor to an activator of gene transcription ( 14 -16 ) . Several target genes of Notch, including Hes1, Hes5, and pT have been identifi ed ( 17, 18 ) . ␥ -secretase inhibitors (GSIs) can eff ectively prevent the enzymatic cleavage of the cytoplasmic domain of Notch receptors, thereby inhibiting the downstream signaling events triggered by activation of these receptors ( 19 ) .
Recently, studies have implicated Notch in activation ( 20 -23 ) and diff erentiation ( 24 -26 ) of cells of the peripheral immune system. The role of Notch signaling, especially in CD8 + T EFF cells, and its involvement in allergen-induced AHR and airway infl ammation have not been defi ned. In this study, we demonstrated Notch1 expression on CD8 + T EFF cells and that inhibition of Notch signaling using GSI reversed their eff ects on development of AHR and airway infl ammation, in part due to the up-regulation of IFN-␥ production. Further, we showed that Delta1, a Notch ligand, is an eff ective inhibitor of allergen-induced AHR.
RESULTS

Notch1 is expressed in T EFF cells but not central memory CD8 + T (T CM ) cells
We previously showed that the development of AHR and eosinophilic infl ammation in CD8 Ϫ / Ϫ mice was lower than in WT mice but could be fully restored after transfer of CD8 + T cells from antigen-primed donors or after transfer of in vitrogenerated CD8 + T EFF cells but not CD8 + T CM cells ( 10 ) . Reconstitution of heightened airway responsiveness by T EFF cells was paralleled by restoration of bronchoalveolar lavage (BAL) and tissue eosinophilia, BAL IL-13 levels, and goblet cell metaplasia. To determine if there were diff erences in gene expression between T EFF and T CM cells, microarray analysis was performed (the microarray data have been deposited in the GEO database under accession number GSM8632). In the analysis of T EFF and T CM cell total RNA, an up-regulation of Notch1 was detected in T EFF cells, which was > 1,000-fold higher than in T CM cells (P < 0.05) ( Fig. 1 A ) . In contrast, the expression of Notch2 and Notch3 was only minimally higher in T EFF cells.
Because Notch is not up-regulated and NICD is not detected until T EFF cells are activated through the antigen receptor (or TCR) ( Fig. 1 B ) , Notch1 expression is not retained on The relative levels of Th1 and Th2 cytokines have been proposed to play an important role in the development of allergic airway infl ammation ( 33 ) . After transfer of T EFF cells pretreated with DMSO into secondary challenged WT mice, IL-4 and IL-13 levels in BAL of recipients of DMSO-T EFF cells were increased, whereas GSI-T EFF cell recipients showed smaller increases in IL-4 and IL-13 but markedly increased levels of IFN-␥ ( Fig. 2 D ) . Similar results on cytokine production were observed when lung cells were assayed (Fig. S2 , available at http://www .jem.org/cgi/content/full/jem.20072200/DC1).
The expression of T-bet and GATA-3 in homogenized lung
Because the balance between the transcription factors T-bet and GATA-3 has been associated with the predominance of Th1 and Th2 responses, respectively ( 12 ), we analyzed levels of these transcription factors using real-time PCR in homogenized lung samples from mice that received GSI-T EFF cells or DMSO-T EFF cells. In parallel to the results of BAL cytokine levels, the expression level of T-bet in recipients of GSI-T EFF cells was signifi cantly higher than in the other groups; the expression level of GATA-3 in GSI-T EFF cell recipients was signifi cantly decreased ( Fig. 2 E ) .
IFN-␥ production in CD4 + or CD8 + T cells
To identify the source of IFN-␥ production in the recipients of GSI-T EFF cells, mononuclear cells (MNCs) were obtained from the lung tissue of recipient WT mice after transfer of either GSI-T EFF cells or DMSO-T EFF cells 48 h after secondary OVA challenge. As shown in Table I , the number of IFN-␥ + cells in the CD4 + fraction of GSI-T EFF cell recipients was signifi cantly higher than in the DMSO-T EFF cell recipients. However, the number of IFN-␥ -producing lung CD8 + T cells was significantly decreased in GSI-T EFF cell recipients compared with DMSO-T EFF cell recipients ( Table I ) .
Effects of GSI-T EFF cell transfer on allergen-induced AHR and airway infl ammation in CD8 -/ -recipients T EFF cells transferred into primary challenged CD8 Ϫ / Ϫ mice restored the full development of AHR and airway infl ammation ( 10 ) . To analyze the role of Notch signaling in the cleaved form of Notch1 using a cleavage-specifi c antibody ( Fig. 1 B ) . Cleaved Notch1 was detected in T EFF cells cultured with either anti-CD3 plus anti-CD28 or SIINFEKL. Treatment with GSI dramatically reduced the levels of cleaved Notch1 protein after TCR or antigen-specifi c activation. Examination of cell proliferation and cell survival showed no eff ect of GSI treatment on these parameters (unpublished data). These data demonstrate that Notch1 signaling can be inhibited pharmacologically in CD8 + T EFF cells activated through the TCR.
Effects of transfer of GSI-T EFF cells on allergen-induced AHR and airway infl ammation in WT mice
To assess the eff ects of the Notch signaling pathway on the enhancement of the functional activity of CD8 + T EFF cells in vivo, GSI-T EFF cells or DMSO-T EFF cells were transferred into sensitized and challenged recipient WT mice before secondary OVA challenge. Secondary challenge of sensitized and challenged mice led to the development of increased AHR in WT mice, illustrated by signifi cant increases in lung resistance (RL) ( Fig. 2 A ) , as described previously in this model ( 31 ) . Fig. 2 A also illustrates the changes in RL in WT recipients of GSI-T EFF cells or DMSO-T EFF cells undergoing secondary challenge. AHR to methacholine (MCh) was signifi cantly increased in recipients of DMSO-T EFF cells, but recipients of GSI-T EFF cells failed to increase AHR over that seen in WT mice not receiving T EFF cells. Indeed, transfer of DMSO-T EFF cells signifi cantly increased AHR, whereas transfer of GSI-T EFF cells inhibited the response to a modest degree. In parallel to the assessment of lung function, the infl ammatory cell composition of BAL fl uid was examined ( Fig. 2 B ) . Eosinophil numbers in BAL fl uid were significantly increased in the DMSO-T EFF cell recipient mice, whereas GSI-T EFF cell recipient mice did not show such increases. In contrast, neutrophil numbers were increased in GSI-T EFF cell recipients. Transfer of either DMSO-T EFF cells or GSF T EFF cells increased lymphocyte numbers in BAL fl uid compared with WT control mice after secondary allergen challenge.
Cell composition of BAL fl uid was examined in WT recipients of GSI-T EFF cells or DMSO-T EFF cells by fl ow cytometry 48 h after the secondary challenge. Previous studies demonstrated that adoptively transferred T EFF cells preferentially migrated into allergen-challenged airways via BLT1 ( 32 ) . The numbers of CD8 + T cells in the BAL fl uid were increased to a similar extent in recipients of either DMSO-T EFF cells or GSI-T EFF cells compared with secondary challenged WT control mice ( Fig. 2 C ) . In addition, the percentages of CD8 + T cells among total BAL cells were higher in both recipients of DMSO-T EFF cells (20.4 ± 1.7%) and GSI-T EFF cells (19.4 ± 1.3%) than in secondary challenged WT control mice (6.6 ± 0.4%). These data demonstrate that the accumulation of CD8 + T cells in the airways after T EFF cell transfer and secondary allergen challenge was not altered by pretreatment with GSI. The results from lung cell digestion were similar to those observed in BAL fl uid (Fig. S1 , available at http://www.jem .org/cgi/content/full/jem.20072200/DC1). Mean values ± SEM are given. WT, OVA-sensitized and challenged WT mice; DMSO-T EFF , DMSO-treated T EFF cell recipient WT mice that were OVA sensitized and challenged; GSI-T EFF , GSI-treated T EFF cell recipient WT mice that were OVA sensitized and challenged. a P < 0.05 compared between GSI-T EFF cells versus WT and DMSO-T EFF cells. b P < 0.05 compared between GSI-T EFF cells versus DMSO-T EFF cells.
reconstituted the development of AHR and eosinophilic airway infl ammation. The development of AHR in CD8 Ϫ / Ϫ recipients of DMSO-T EFF cells was not signifi cantly diff erent from WT recipients of DMSO-T EFF cells. Transfer of GSI-T EFF cells into CD8 Ϫ / Ϫ failed to increase AHR or airway eosinophilia, but it did increase the numbers of neutrophils reconstitution of CD8 Ϫ / Ϫ mice after secondary allergen challenge, GSI-T EFF cells or DMSO-T EFF cells were transferred into sensitized and challenged CD8 Ϫ / Ϫ mice before secondary allergen challenge. As shown in Fig. 3 (A and B) , CD8 Ϫ / Ϫ mice developed signifi cantly lower responses after secondary allergen challenge. Transfer of DMSO-T EFF cells #, signifi cant difference (P < 0.05) between GSI-T EFF cell recipients and DMSO-T EFF cell recipients; ‡ , signifi cant difference (P < 0.05) between DMSO-T EFF cell recipients and WT control mice; *, signifi cant difference (P < 0.05) between GSI-T EFF cell recipients and WT mice. (C) CD4 + and CD8 + T cells in BAL fl uid. ‡ , signifi cant difference (P < 0.05) between DMSO-T EFF cell recipients and WT control mice; *, signifi cant difference (P < 0.05) between GSI-T EFF cell recipients and WT mice. (D) Cytokine levels in BAL fl uid of WT mice that received GSI-T EFF or DMSO-T EFF cells. #, signifi cant difference (P < 0.05) between GSI-T EFF cell recipients and DMSO-T EFF cell recipients; ‡ , signifi cant difference (P < 0.05) between DMSO-T EFF cell recipients and WT control mice; *, signifi cant difference (P < 0.05) between GSI-T EFF cell recipients and WT control mice. (E) Relative expression levels of GATA-3 and T-bet in the lung were determined by quantitative real-time PCR. Lung cells are from the same groups as described in A. They were isolated using collagenase digestion, and RNA was prepared. Results are representative of three independent experiments. The results for each group are expressed as mean ± SEM. #, signifi cant difference (P < 0.05) between GSI-T EFF cell -transferred mice and DMSO-T EFF celltransferred mice or WT control mice.
from the lungs of secondary challenged CD8 Ϫ / Ϫ recipients of either GSI-T EFF cells or DMSO-T EFF cells and analyzed by real-time PCR. T cells are reported to express the Notch ligands Delta1 ( 34 ), Jagged1 ( 35 ) , and Jagged2 ( 36 ) . In parallel to the data on BAL (and lung cell) cytokine production and the induction of T-bet expression in the lung, we showed that the level of Delta1 expression was higher in isolated GSI-T EFF cells compared with isolated DMSO-T EFF cells ( Fig. 4 ) . Baseline levels of Delta1 expression in either GSI-T EFF cells or DMSO-T EFF cells before transfer were extremely low in the absence of activation. There were no signifi cant diff erences in the levels of expression of the other Notch ligands (Jagged1 and Jagged2).
Effects of administration of Delta1-Fc to WT mice on allergen-induced AHR and airway infl ammation
To directly test whether Delta1 regulates AHR and airway infl ammation, sensitized and challenged WT mice were treated with Delta1-Fc or human IgG as a control before secondary OVA challenge (OVA/OVA/OVA) ( Fig. 5 A ) . Administration in BAL fl uid. IFN-␥ levels in BAL fl uid were also increased in GSI-T EFF cell recipients compared with recipients of DMSO-T EFF cells, whereas the opposite was true for IL-4 and IL-13 ( Fig. 3 C ) . MNCs were obtained from the lung tissue of recipient CD8 -/ -mice after the transfer of either GSI-T EFF cells or DMSO-T EFF cells 48 h after secondary challenge and assessed by fl ow cytometry ( Table II ) . The number of CD4 + IFN-␥ + T cells in GSI-T EFF cell recipients was signifi cantly higher than in the DMSO-T EFF cell recipients. However, the number of IFN-␥ -producing lung CD8 + T cells was lower in GSI-T EFF cell recipients than in DMSO-T EFF cell recipients. Based on these results, it appeared that the source of increased IFN-␥ production and Th1 polarization was lung CD4 + T cells in the recipients of GSI-T EFF cells.
Expression of Delta1 in T EFF cells from CD8 ؊ / ؊ recipients of GSI-T EFF cells or DMSO-T EFF cells
To determine if Notch ligand expression was involved in the response of the transferred cells, CD8 + T EFF cells were isolated The results for each group are expressed as the mean ± SEM ( n = 12). #, signifi cant difference (P < 0.05) between GSI-T EFF cell recipients and DMSO-T EFF cell recipients; ‡ , signifi cant difference (P < 0.05) between DMSO-T EFF cell recipients and controls; *, signifi cant difference (P < 0.05) between GSI-T EFF cell recipients and controls.
these groups. The results in BAL fl uid were confi rmed using lung cells (Fig. S3 , available at http://www.jem.org/cgi/content/ full/jem.20072200/DC1).
DISCUSSION
The Notch signaling pathway is a highly conserved program for cell fate decisions in all organisms, infl uencing apoptosis or cell cycle arrest ( 37, 38 ) . The signal induced by ligand binding is conveyed intracellularly by a process involving proteolytic cleavage of the receptor and nuclear translocation of the intracellular domain of the Notch family protein. The GSIs prevent the generation of the NICD and suppress Notch activity. In the immune system, several studies have implicated Notch signaling in hematopoiesis, T -B lineage commitment, and thymic T cell development ( 16, 39 -41 ) . Notch gene expression is induced and Notch1 is activated after CD4 + T cell activation, possibly through a " positive feedback loop " in adjacent cells ( 21 ) . Studies have also suggested that Notch may infl uence both Th1 and Th2 polarization ( 25, 26 ) .
In contrast to several reports that analyzed the relationship between CD4 + T cells and Notch in the peripheral immune system, there is a paucity of information regarding a role for Notch signaling in CD8 + T cells. Several studies have suggested that the activation of Notch suppresses CD8 + T cell eff ector functions ( 23, 42 ) . On the other hand, Palaga et al. ( 20 ) reported that the number of IFN-␥ -producing CD8 + T cells was signifi cantly reduced by inhibition of Notch signaling, indicating that the activation of Notch may be required for CD8 + T cell function.
There is now increasing evidence that in addition to CD4 + T cells, CD8 + T cells contribute to the development of allergic disease ( 7 -10, 43 -45 ) . In the development of CD8 + T cellmediated AHR and eosinophilic infl ammation, CD4 + T cells play an essential role in the sensitization phase ( 11 ) . We previously showed that CD8 -/ -mice develop lower levels of AHR and eosinophilic infl ammation compared with WT mice, and these responses can be restored by transfer of in vivo -activated CD8 + T cells from antigen-primed donors or by transfer of in vitro -generated CD8 + T EFF cells, but not CD8 + T CM cells, before challenge ( 9, 10 ) . Recently, we showed that T EFF cells upregulate BLT1 ( 32 ), the high affi nity receptor for LTB4 ( 46 ) , and BLT1 plays a critical role in the recruitment of T EFF cells into allergen-challenged lungs resulting in AHR and airway infl ammation ( 32 ) .
In this study, we used transcript expression profi le analysis to defi ne gene diff erences between T EFF and T CM cells. In light of the fi ndings that Notch1 expression was much higher in CD8 + T EFF than T CM cells, we investigated the role of this signaling molecule in CD8-mediated allergic airway responses. We fi rst demonstrated that Notch can signal T EFF cells and determined the role of this signaling pathway using a pharmacological approach. We showed that after incubation of CD8 + T EFF cells with anti-CD3/anti-CD28 or the addition of SIINFEKL, cleaved Notch1 could be detected confi rming Notch signaling, and incubation of T EFF cells with the GSI prevented this cleavage in vitro.
of Delta1-Fc markedly reduced AHR compared with administration of (control) human IgG in response to secondary allergen challenge ( Fig. 5 B ) . Neither Delta1-Fc nor human IgG altered the response in control mice (OVA/OVA/PBS). In parallel, administration of Delta1-Fc to secondary challenged mice markedly reduced the numbers of eosinophils and levels of IL-13 in the BAL fl uid without aff ecting these responses in controls ( Fig. 5, C and D ) .
Administration of Delta1-Fc to secondary challenged mice resulted in signifi cantly increased levels of IFN-␥ in the BAL fl uid. To confi rm these eff ects of Delta1-Fc and IFN-␥ production, MNCs were obtained from the lung tissue of secondary challenged mice or control mice. As shown in Fig. 5 E , the number of CD4 + IFN-␥ + T cells in mice treated with Delta1-Fc was signifi cantly higher than in those that received human IgG (or controls that received Delta1-Fc or human IgG). However, the number of CD8 + IFN-␥ + lung CD8 + T cells was not significantly different among any of intranasal administration of IFN-␥ eff ectively inhibited goblet cell metaplasia ( 49 ) . Additionally, IFN-␥ has been shown to inhibit airway smooth muscle contraction ( 50 ) and proliferation ( 51 ) . Diff erentiation of Th1 and Th2 cells is tightly crossregulated so that development of one subset is inhibited by cytokines produced by the other ( 52 ) . T-box expressed in T cells (T-bet) plays a central role in Th1 development by activating Th1 genetic programs, IFN-␥ production, and repressing Th2 cytokine synthesis ( 52 ) . In contrast, GATA-3 serves as a Th2 cytokine-specifi c transcription factor selectively expressed in Th2 cells ( 53, 54 ) and leads to inhibition of IFN-␥ production ( 55 ). In the secondary challenge model, transfer of GSI-treated T EFF cells shifted the balance with modest increases and decreases in T-bet and GATA-3, respectively, accompanied by failure to enhance lung allergic responses. However, the balance was not shifted to the extent that the transfer of GSI-treated T EFF cells prevented sensitized and challenged host cells from contributing to the lung allergic responses.
These observations were extended to assess the eff ects of preventing Notch cleavage in vivo. To eff ectively maintain GSI interference, we used a secondary challenge protocol in which the analysis of AHR was completed within 48 h of transfer of GSI-treated CD8 + T EFF cells ( 27 ) . In sensitized and challenged WT recipients, secondary challenge elicited AHR and airway infl ammation. Transfer of DMSO (control)-treated T EFF cells led to further increases in AHR, airway eosinophilia, and BAL IL-4 and IL-13 levels. In contrast, transfer of GSI-treated T EFF cells failed to enhance the responses over those seen in WT mice. Notably, levels of BAL IFN-␥ were markedly increased in these recipients as were the levels of expression of T-bet with a decrease in GATA-3 expression. These results were not attributable to diff erences in the ability of GSI-T EFF cells to accumulate in the lung, as the numbers of GSI-and DMSO-treated cells in the lung were the same. The failure of GSI-T EFF cells to enhance AHR or eosinophilic airway infl ammation could be attributed to the increases in IFN-␥ production. We previously demonstrated that IFN-␥ has the potential to inhibit AHR ( 47, 48 ) and that ciated with increased numbers of CD4 + IFN-␥ + T cells in secondary challenged mice. These data are consistent with reports that Delta1 interacts with CD4 + T cells and enhances IFN-␥ production in antigen-stimulated CD4 + T cells ( 25, 26 ) .
To further extend these observations, we examined the consequences of administering a Delta1-Fc protein before secondary challenge. Administration of Delta1-Fc resulted in increased IFN-␥ production from CD4 + T cells, and this was associated with a signifi cant inhibition of the development of AHR, airway eosinophilia, and BAL IL-13 levels. At the same time, BAL IFN-␥ levels were increased. These results are similar to recent observations in experimental autoimmune encephalomyelitis, where treatment with Delta1-Fc increased the number of Th1 cells in the central nervous system ( 58 ) . Control mice that received Delta1-Fc did not increase the number of IFN-␥ -producing lung CD4 + T cells, suggesting that in the absence of activation, the expression of Notch is not up-regulated and that interactions between Notch receptor and Delta1-Fc do not take place. In recipients of Delta1-Fc, we detected the highest numbers of CD4 + IFN-␥ + T cells and levels of IFN-␥ , accompanied by markedly reduced levels of IL-4 and IL-13 in secondary challenged mice (Fig. S3) .
After adoptive transfer, CD8 + T EFF cells in the lung exhibit a Th2 phenotype ( 10, 32 ) . Thus, the phenotype of predominant Th1-type cytokine-producing CD8 + T cells could be redirected toward Th2-type cytokine production in the lungs of sensitized and challenged mice, a plasticity previously emphasized in CD4 + T cells ( 59 ) . As a result of the inhibition of Notch signaling by GSI, Th2 cytokine production by these lung CD8 + T EFF cells was superseded by Notch receptorNotch ligand interactions and increased IFN-␥ production in CD4 + T cells. Collectively, these data identify a new pathway involved in the regulation of CD4 + -CD8 + T cell interactions and the development of Th2-mediated allergic responses through Notch signaling. The pathway appears tightly regulated by the expression pattern of Notch receptor and the Delta1 Notch ligand, which are in turn dependent on the activation of T cells. The data reveal the therapeutic potential of Delta1-Fc in the regulation of allergen-induced AHR.
MATERIALS AND METHODS
Mice. WT C57BL/6 and OT-1 mice (C57BL/6 strain) expressing a transgenic TCR that is specifi c for OVA 257 -264 (SIINFEKL) peptide ( 60 ) were purchased from The Jackson Laboratory. Homozygous CD8-defi cient (CD8 Ϫ / Ϫ ) mice, generated by targeting the CD8 ␣ chain gene in C57BL/6 mice ( 61 ), were obtained from P. Marrack (National Jewish Medical and Research Center, Denver, CO). Each experiment was independently performed at least three times with four mice/group ( n = 12). Controls were matched with the defi cient mice with regard to both age and gender in each experimental group. All studies were conducted under a protocol approved by the Institutional Animal Care and Use Committee of the National Jewish Medical and Research Center.
Cell (CD8 T cell) preparation and culture. Diff erentiation of T EFF and T CM cells in vitro was performed as described previously ( 62, 63 ) . For proliferation assays, T EFF cells on day 6 were cultured with GSI or DMSO and IL-2 for 24 h, followed by cell count analysis (Coulter Counter). For the protein and RNA assays, isolated T EFF cells were stimulated with 2 μ g/ml of plate-bound anti-CD3 plus 2 μ g/ml anti-CD28 (R & D Systems) or 1 μ g/ml SIINFEKL peptide in the presence of DMSO (0.1% fi nal concentration) or A similar pattern was seen in CD8 Ϫ / Ϫ recipients where transfer of GSI-treated T EFF cells, unlike DMSO-treated T EFF cells, failed to reconstitute AHR, airway eosinophilia, or BAL IL-13 levels. As in WT recipients, transfer of GSI-treated T EFF cells resulted in increased IFN-␥ levels in BAL. In vitro, incubation of GSI-treated T EFF cells with anti-CD3/anti-CD28 or SIINFEKL did lead to decreased expression of Notch1 mRNA (unpublished data), in keeping with the reduced levels of Notch1 cleavage protein determined by Western blotting. In parallel, activation through the TCR of the GSI-treated T EFF cells led to increases in the expression of Delta1 mRNA. However, these changes were only seen when GSI-T EFF cells were co-cultured with CD8 + T EFF cells during the activation period, but not when the GSI-T EFF cells were cultured alone (Fig. S4 , available at http://www.jem.org/ cgi/content/full/jem.20072200/DC1). After GSI-T EFF cell transfer and recovery from the lungs of secondary challenged CD8 Ϫ / Ϫ mice, we noted a marked up-regulation of Delta1 mRNA compared with recovered DMSO-treated T EFF cells, with little or no diff erence between the two in levels of Jagged1 or Jagged2 mRNA.
Notch -Notch ligand interactions govern cell fate decisions in T cells. Notch signaling can direct Th2 diff erentiation via GATA-3 ( 56, 57 ) . In vertebrates, Notch can bind to two diff erent families of ligands, Delta-like ( 34 ) and Jagged1 and Jagged2 ( 35, 36 ) . Stimulation of naive CD4 + T cells with Delta1 involving interactions with Notch3 promotes the diff erentiation toward the Th1 pathway ( 25 ) , whereas Jagged1-mediated Notch1 activation is critical in driving Th2 diff erentiation ( 26 ) . As a rule, the ligands tend to be expressed in a more highly restricted pattern than their receptors.
These eff ects of GSI on CD8 + T EFF cells decreasing Notch1 expression, reducing Notch1 cleavage, and increasing T-bet and Delta1 expression, and the associated inhibition of enhancement or failure to restore lung allergic responses together with increased IFN-␥ production, indicated that NotchDelta1 pathways were critical regulators of AHR and Th2 lung allergic responses. The GSI reduced the amount of Notch signaling to potentially mimic a Notch1 loss of function phenotype. It appears that activated T cells, and CD8 + T cells in particular, pretreated with GSI produce little IFN-␥ ( 20 ). We analyzed IFN-␥ secretion in TCR-activated GSI-T EFF cells and found production to be signifi cantly decreased compared with similarly treated DMSO-T EFF cells (Fig. S5 , available at http://www.jem.org/cgi/content/full/jem.20072200/DC1). After transfer, the majority of IFN-␥ -producing cells were localized to the CD4 + subset. The data imply that the increase in CD4 + IFN-␥ + T cells resulted from the changes in Notch signaling ligands expressed on the CD8 + GSI-T EFF cells, i.e., up-regulation of Delta1 on GSI-T EFF cells interacting with Notch receptors on CD4 + T cells. The total numbers of CD4 + T cells in BAL fl uid ( Fig. 2 C ) and lung (Fig. S1) in the presence of 10 μ g/ml brefeldin A (Sigma-Aldrich). After staining for cell surface markers, cells were fi xed with 4% paraformaldehyde in PBS, permeabilized in 0.1% saponin, and stained for intracytoplasmic IFN-␥ (BD Biosciences). The number of IFN-␥ -producing CD4 + or CD8 + T cells per lung was calculated from the percentage of total cells. Stained cells were analyzed on a FACSCalibur (BD Bioscience) using CELLQuest software.
Isolation of GSI-T EFF or DMSO-T EFF cells from the lungs of sensitized and challenged recipients. Lung MNCs were isolated from sensitized and challenged CD8 Ϫ / Ϫ mice that received GSI-T EFF or DMSO-T EFF cells before secondary challenge. CD8 + T cells were positively selected using magnetic beads coated with anti-CD8 antibody (Miltenyi Biotec). RNA was extracted from these isolated CD8 + GSI-T EFF or DMSO-T EFF cells and analyzed by real-time PCR.
Real-Time PCR. Real-time cDNA primers and probes for murine T-bet, GATA-3, Delta1, Jagged1, Jagged2, and GAPDH were obtained from Applied Biosystems. The Delta Delta cycle threshold method was performed for relative quantifi cation of mRNA expression.
Statistical analysis.
All results were expressed as the mean ± SEM as a standard method of presentation for this type of data. The Tukey-Kramer test was used for comparisons between multiple groups. Nonparametric analysis using the Mann-Whitney U test was also used to confi rm that the statistical diff erences remained signifi cant even if the underlying distribution was uncertain. The p-values for signifi cance were set to 0.05 for all tests.
Online supplemental material. Fig. S1 shows the number of CD4 + and CD8 + T cells in the lungs of WT recipients of DMSO-T EFF or GSI-T EFF cells. Fig. S2 illustrates cytokine production from the lung cells of WT recipients of DMSO-T EFF or GSI-T EFF cells. Fig. S3 illustrates cytokine production from lung cells in the recipients of Delta1-Fc. Fig. S4 shows expression levels of Delta1 on DMSO-T EFF or GSI-T EFF cells cultured together with T EFF cells. Fig. S5 shows IFN-␥ production in GSI-T EFF cells. Figs. S1 -S5 are available at http://www.jem.org/cgi/content/full/jem.20072200/DC1. 20 μ M GSI (dibenzapine; EMD) for 24 h. These T EFF cells were washed for immunoblot analysis, or total RNA was extracted from these T EFF cells and analyzed by real-time PCR. All data were representative of at least three independent experiments.
Preparation of RNA for microarray analysis. RNA was extracted from T EFF and T CM cells using the TRIzol reagent as per the manufacturer ' s instructions, and microarray hybridizations were performed using the murine MGU74Av2 Gene Chip (Aff ymetrix). GENESPRING 5.1 was used to analyze resulting data. Gene lists were generated by comparing raw data values of each cell using one-way analysis of variance (P < 0.05 with a BenjaminiHochberg correction).
Western blot analysis. Proteins were resolved by SDS-PAGE and transferred to nitrocellulose membranes. The membranes were treated as recommended by the antibody manufacturer for cleaved Notch1 (Val1744; Cell Signaling Technology). For detection of the specifi c protein, a sensitive chemiluminescence method was used with an appropriate IgG antibody linked to horseradish peroxidase antibody (Thermo Fisher Scientifi c).
Sensitization and challenge. The experimental protocol for sensitization and challenge to allergen was described previously ( 27 ) . Mice were challenged (primary) via the airways with OVA (0.2% in saline) for 20 min on days 14, 15, and 16 using an ultrasonic nebulizer (model NE-U07; Omron Healthcare). On day 30, mice received a single secondary challenge via the airways with 1% OVA for 20 min (OVA/OVA/OVA). Control mice were sensitized and challenged to OVA, and on day 30 they received PBS (OVA/ OVA/PBS). On day 32, airway function was measured as described below, followed by collection of samples for further analyses.
Assessment of airway function. Airway function was assessed as described previously by measuring changes in RL in response to increasing doses of inhaled MCh ( 31 ) . Data are expressed as percent change from baseline RL values obtained after inhalation of saline.
BAL.
Immediately after measurement of AHR, lungs were lavaged with HBSS and total leukocyte numbers were analyzed. BAL fl uid was collected, and numbers of CD4 + and CD8 + T cells were analyzed by fl ow cytometry.
Adoptive transfer of GSI-treated T EFF cells and administration of Delta1-Fc. For adoptive transfer, 5 × 10 6 T EFF cells pretreated with GSI (GSI-T EFF cells) or DMSO (DMSO-T EFF cells) were administered intravenously through the tail vein to OVA primary sensitized/challenged WT and CD8 -/ -mice 2 wk after the last challenge (day 30). After transfer, the mice were exposed to a single (secondary) allergen challenge via the airways on day 30. All assays were performed on day 32. The nontransferred WT or CD8 Ϫ / Ϫ mice were assigned as controls. In the Delta1-Fc protocol, soluble Delta1-Fc ( 25, 64 ) was injected intraperitoneally at a dose of 50 μ g each day beginning 4 d before and through the day after secondary challenge in WT mice that had undergone primary sensitization and challenge with OVA. As a control, 50 μ g of human IgG was administered in the same manner. 48 h after the single (secondary) allergen challenge, all assays were performed.
Measurement of cytokines.
Cytokine levels in the BAL fl uid and cell culture supernatants were measured by ELISA as described previously ( 65 ) . The limits of detection were 4 pg/ml for IL-4, IL-5, and IL-13 and 10 pg/ml for IL-10 and IFN-␥ .
Lung cell isolation and fl ow cytometry. MNCs from the left lung were isolated as described previously using collagenase digestion ( 66 ) . BAL cells and enriched lung MNCs were labeled with anti-CD3, anti-CD4, and anti-CD8 (BD Biosciences). The number of CD4 + and CD8 + T cells per BAL was derived by multiplying the percentage of stained cells by the total number of BAL cells isolated. For intracellular staining, lung MNCs were stimulated with 5 ng/ml PMA and 500 ng/ml ionomycin (Sigma-Aldrich) for 6 h
